CVS Health Co. (NYSE:CVS) Shares Sold by Frazier Financial Advisors LLC

Frazier Financial Advisors LLC lowered its position in shares of CVS Health Co. (NYSE:CVS) by 16.9% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,339 shares of the pharmacy operator’s stock after selling 272 shares during the period. Frazier Financial Advisors LLC’s holdings in CVS Health were worth $84,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Livelsberger Financial Advisory acquired a new stake in CVS Health in the 3rd quarter valued at approximately $31,000. Reston Wealth Management LLC acquired a new stake in CVS Health in the 3rd quarter valued at approximately $32,000. First Community Trust NA increased its holdings in CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock valued at $33,000 after purchasing an additional 302 shares during the last quarter. Kathleen S. Wright Associates Inc. acquired a new stake in CVS Health in the 3rd quarter valued at approximately $33,000. Finally, ORG Partners LLC increased its holdings in CVS Health by 11,840.0% in the 2nd quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 592 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently weighed in on the stock. StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday. Cantor Fitzgerald restated a “neutral” rating and issued a $62.00 price target on shares of CVS Health in a research note on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft dropped their price target on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research note on Friday, August 9th. Evercore ISI boosted their price target on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. Finally, Wells Fargo & Company dropped their price target on shares of CVS Health from $61.00 to $60.00 and set an “equal weight” rating for the company in a research note on Monday, November 4th. One investment analyst has rated the stock with a sell rating, eight have given a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $72.44.

CVS Health Stock Performance

NYSE:CVS opened at $53.19 on Friday. The firm has a market cap of $66.93 billion, a price-to-earnings ratio of 13.50, a price-to-earnings-growth ratio of 0.92 and a beta of 0.55. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. CVS Health Co. has a 1-year low of $52.71 and a 1-year high of $83.25. The firm’s fifty day moving average price is $59.23 and its 200 day moving average price is $58.66.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating the consensus estimate of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The business’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.21 earnings per share. On average, sell-side analysts expect that CVS Health Co. will post 5.48 EPS for the current year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were issued a $0.665 dividend. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 5.00%. CVS Health’s dividend payout ratio is currently 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.